vs

Side-by-side financial comparison of CLOVER HEALTH INVESTMENTS, CORP. (CLOV) and MongoDB, Inc. (MDB). Click either name above to swap in a different company.

MongoDB, Inc. is the larger business by last-quarter revenue ($628.3M vs $487.7M, roughly 1.3× CLOVER HEALTH INVESTMENTS, CORP.). MongoDB, Inc. runs the higher net margin — -0.3% vs -10.1%, a 9.8% gap on every dollar of revenue. On growth, CLOVER HEALTH INVESTMENTS, CORP. posted the faster year-over-year revenue change (44.7% vs 18.7%). MongoDB, Inc. produced more free cash flow last quarter ($141.8M vs $-69.0M). Over the past eight quarters, CLOVER HEALTH INVESTMENTS, CORP.'s revenue compounded faster (18.6% CAGR vs 17.1%).

Clover Health Investments, Corp. is an American health care company founded in 2014. The company provides Medicare Advantage (MA) insurance plans and operates as a direct contracting entity with the U.S. government. The company manages care for Medicare beneficiaries in 11 states and started trading publicly on January 8, 2021.

MongoDB, Inc. is an American software company that develops and provides commercial support for the source-available database engine MongoDB, a database for unstructured data. Over the years, the company has expanded the product from its NoSQL roots to have broader appeal to enterprise customers, such as adding ACID and transactions.

CLOV vs MDB — Head-to-Head

Bigger by revenue
MDB
MDB
1.3× larger
MDB
$628.3M
$487.7M
CLOV
Growing faster (revenue YoY)
CLOV
CLOV
+26.0% gap
CLOV
44.7%
18.7%
MDB
Higher net margin
MDB
MDB
9.8% more per $
MDB
-0.3%
-10.1%
CLOV
More free cash flow
MDB
MDB
$210.8M more FCF
MDB
$141.8M
$-69.0M
CLOV
Faster 2-yr revenue CAGR
CLOV
CLOV
Annualised
CLOV
18.6%
17.1%
MDB

Income Statement — Q4 FY2025 vs Q3 FY2026

Metric
CLOV
CLOV
MDB
MDB
Revenue
$487.7M
$628.3M
Net Profit
$-49.3M
$-2.0M
Gross Margin
71.5%
Operating Margin
-10.1%
-2.9%
Net Margin
-10.1%
-0.3%
Revenue YoY
44.7%
18.7%
Net Profit YoY
-123.2%
79.5%
EPS (diluted)

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CLOV
CLOV
MDB
MDB
Q4 25
$487.7M
$628.3M
Q3 25
$496.6M
$591.4M
Q2 25
$477.6M
$549.0M
Q1 25
$462.3M
$548.4M
Q4 24
$337.0M
$529.4M
Q3 24
$331.0M
$478.1M
Q2 24
$356.3M
$450.6M
Q1 24
$346.9M
$458.0M
Net Profit
CLOV
CLOV
MDB
MDB
Q4 25
$-49.3M
$-2.0M
Q3 25
$-24.4M
$-47.0M
Q2 25
$-10.6M
$-37.6M
Q1 25
$-1.3M
$15.8M
Q4 24
$-22.1M
$-9.8M
Q3 24
$-9.2M
$-54.5M
Q2 24
$7.4M
$-80.6M
Q1 24
$-19.2M
$-55.5M
Gross Margin
CLOV
CLOV
MDB
MDB
Q4 25
71.5%
Q3 25
71.0%
Q2 25
71.2%
Q1 25
72.8%
Q4 24
74.4%
Q3 24
24.5%
73.2%
Q2 24
30.3%
72.8%
Q1 24
23.6%
75.0%
Operating Margin
CLOV
CLOV
MDB
MDB
Q4 25
-10.1%
-2.9%
Q3 25
-4.9%
-11.0%
Q2 25
-2.2%
-9.8%
Q1 25
-0.3%
-3.4%
Q4 24
-6.4%
-5.3%
Q3 24
-2.7%
-14.9%
Q2 24
2.0%
-21.8%
Q1 24
-6.5%
-15.5%
Net Margin
CLOV
CLOV
MDB
MDB
Q4 25
-10.1%
-0.3%
Q3 25
-4.9%
-8.0%
Q2 25
-2.2%
-6.9%
Q1 25
-0.3%
2.9%
Q4 24
-6.6%
-1.8%
Q3 24
-2.8%
-11.4%
Q2 24
2.1%
-17.9%
Q1 24
-5.5%
-12.1%

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CLOV
CLOV
MDB
MDB
Cash + ST InvestmentsLiquidity on hand
$78.3M
$834.1M
Total DebtLower is stronger
Stockholders' EquityBook value
$308.7M
$2.9B
Total Assets
$541.0M
$3.6B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CLOV
CLOV
MDB
MDB
Q4 25
$78.3M
$834.1M
Q3 25
$647.1M
Q2 25
$657.8M
Q1 25
$490.1M
Q4 24
$194.5M
$673.1M
Q3 24
$288.0M
$1.3B
Q2 24
$254.8M
$815.7M
Q1 24
$208.3M
$803.0M
Stockholders' Equity
CLOV
CLOV
MDB
MDB
Q4 25
$308.7M
$2.9B
Q3 25
$340.9M
$2.9B
Q2 25
$344.2M
$3.0B
Q1 25
$336.1M
$2.8B
Q4 24
$341.1M
$1.5B
Q3 24
$342.2M
$1.4B
Q2 24
$324.9M
$1.3B
Q1 24
$292.5M
$1.1B
Total Assets
CLOV
CLOV
MDB
MDB
Q4 25
$541.0M
$3.6B
Q3 25
$559.7M
$3.5B
Q2 25
$575.0M
$3.6B
Q1 25
$583.7M
$3.4B
Q4 24
$580.7M
$3.2B
Q3 24
$653.0M
$3.1B
Q2 24
$674.2M
$3.0B
Q1 24
$671.8M
$2.9B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CLOV
CLOV
MDB
MDB
Operating Cash FlowLast quarter
$-66.9M
$143.5M
Free Cash FlowOCF − Capex
$-69.0M
$141.8M
FCF MarginFCF / Revenue
-14.1%
22.6%
Capex IntensityCapex / Revenue
0.4%
0.3%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-69.2M
$346.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CLOV
CLOV
MDB
MDB
Q4 25
$-66.9M
$143.5M
Q3 25
$12.1M
$72.1M
Q2 25
$5.4M
$109.9M
Q1 25
$-16.3M
$50.5M
Q4 24
$34.8M
$37.4M
Q3 24
$50.0M
$-1.4M
Q2 24
$44.8M
$63.6M
Q1 24
$25.9M
$54.6M
Free Cash Flow
CLOV
CLOV
MDB
MDB
Q4 25
$-69.0M
$141.8M
Q3 25
$11.4M
$71.6M
Q2 25
$4.8M
$108.3M
Q1 25
$-16.5M
$24.6M
Q4 24
$33.3M
$35.5M
Q3 24
$49.6M
$-2.4M
Q2 24
$44.4M
$63.1M
Q1 24
$25.5M
$51.9M
FCF Margin
CLOV
CLOV
MDB
MDB
Q4 25
-14.1%
22.6%
Q3 25
2.3%
12.1%
Q2 25
1.0%
19.7%
Q1 25
-3.6%
4.5%
Q4 24
9.9%
6.7%
Q3 24
15.0%
-0.5%
Q2 24
12.5%
14.0%
Q1 24
7.3%
11.3%
Capex Intensity
CLOV
CLOV
MDB
MDB
Q4 25
0.4%
0.3%
Q3 25
0.1%
0.1%
Q2 25
0.1%
0.3%
Q1 25
0.0%
4.7%
Q4 24
0.5%
0.4%
Q3 24
0.1%
0.2%
Q2 24
0.1%
0.1%
Q1 24
0.1%
0.6%
Cash Conversion
CLOV
CLOV
MDB
MDB
Q4 25
Q3 25
Q2 25
Q1 25
3.19×
Q4 24
Q3 24
Q2 24
6.04×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CLOV
CLOV

Segment breakdown not available.

MDB
MDB

Mongo DB Atlas Related$470.4M75%
Other Subscription$138.7M22%
Services$19.2M3%

Related Comparisons